In September 2018, following its approval by the FDA for rare types of childhood epilepsy, Epidiolex was rescheduled (by the Drug Enforcement Administration) as a Schedule V drug to allow for its prescription use. This change applies only to FDA-approved products containing no more than 0.1 percent THC. This allows GW Pharmaceuticals to sell Epidiolex, but it does not apply broadly and all other CBD-containing products remain Schedule I drugs. Epidiolex still requires rescheduling in some states before it can be prescribed in those states.
Online business is how I’ve made a living since 2003 and what has helped me retire early. I make over $40,000 a month through my blog. You can create your own blog here with my easy 15-minute step-by-step tutorial. You can start a blog for as little as $2.95 a month (less than a cup of coffee!). Create a blog and leverage it into affiliate sales or product endorsement deals. Consider topics like: